NEW YORK, Nov. 12-Sunergia Medical and Estonia's Asper Biotech will jointly offer genotyping services and systems in North America, the two companies said yesterday.
The firms will offer genotyping services for medium- and large-scale projects, including DNA analysis, bioinformatics, and microarray printing.
They will also market the Genorama QuattroImager, a microarray imaging and analysis system developed by Asper.
Financial details of the partnership were not disclosed.
Asper Biotech, based in Tartu, Estonia, sells high-throughput SNP-genotyping instruments. Its partners include EGeen.
Sunergia Medical is a division of Sunergia Group, which is based in Reston, Va. It sells instruments, software, supplies and services for biotechnology research, focusing on genomics and proteomics.